SCHEMBL4486106

SCHEMBL4486106

CCOc1cccc(-c2ccc3c(NC(=O)c4ccc(Cl)cc4Cl)n[nH]c3c2)c1

nearest known ligand 0.70

Predicted protein targets (top 11)

geneUniProtsupporting neighboursconfidence
FGFR1 P11362 3/20 0.70
FGFR2 P21802 1/20 0.70
FGFR3 P22607 1/20 0.70
HDAC6 Q9UBN7 7/20 0.68
HDAC1 Q13547 6/20 0.61
HDAC2 Q92769 6/20 0.61
HDAC8 Q9BY41 6/20 0.61
PPARG P37231 1/20 0.61
FGFR4 P22455 1/20 0.53
TP53 P04637 1/20 0.50
GSK3B P49841 1/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4497949 0.85 GSK3B (0.55) FGFR1FGFR2FGFR3HDAC6HDAC1
SCHEMBL4502526 0.84 FGFR1 (0.70) FGFR1FGFR2FGFR3HDAC6HDAC1
SCHEMBL4490651 0.83 HDAC1 (0.68) FGFR1FGFR2FGFR3HDAC6HDAC1
SCHEMBL4490018 0.83 HDAC6 (0.60) FGFR1FGFR2FGFR3HDAC6HDAC1
SCHEMBL4491557 0.83 FGFR1 (0.69) FGFR1FGFR2FGFR3HDAC6HDAC1
SCHEMBL4486549 0.83 FGFR1 (0.69) FGFR1FGFR2FGFR3HDAC6HDAC1
SCHEMBL4491807 0.83 FGFR1 (0.75) FGFR1FGFR2FGFR3HDAC6HDAC1
SCHEMBL4506750 0.82 FGFR1 (0.70) FGFR1FGFR2FGFR3HDAC6HDAC1
SCHEMBL4484043 0.82 HDAC6 (0.58) FGFR1FGFR2FGFR3HDAC6HDAC1
SCHEMBL4496669 0.81 FGFR1 (0.75) FGFR1FGFR2FGFR3HDAC6HDAC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7632854-B2 Aminoindazole derivatives active as kinase inhibitors, process for their preparation and pharmaceutical compositions comprising them PFIZER ITALIA S.R.L. (IT) 2009-12-15 US claimed